South Carolina 2025-2026 Regular Session Status: In Committee

S 1039 — Schedule I substances

Last action — Referred to Committee on Medical Affairs

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced March 19, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Stalled 18% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 3 sponsors

    3 primary, 0 co-sponsors signed on.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

A BILL TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-190, RELATING TO SCHEDULE I SUBSTANCES, SO AS TO ADD SUBSTITUTED TRYPTAMINES TO THE LIST OF SCHEDULE I SUBSTANCES.

Bill Text

What changed in the latest version

168 added · 9 removed

168 line(s) added, 9 removed.

→
Previous
Latest
PK ³€x\¥ÝŽw Ú customXml/item5.xml½WÝn£F¾ïS _lnBƒI¶& »\ÚF«`H¬`ˆN6ªVê+ôû$=`ócâlï*ÙFÌ÷3ç‡3ãùÇo›”y¦ÛbgWgüwÆÐ,ÊãuvuæãkvvÆ%Éb’æ½:Ëò³êOóô%$nIK“’0`’W£‡²|º‹ènHq‘?ѐ$ßnH ·Ûûñ‰É=O8NoòñލmîGêÜpt‰là»Rë4Çæצ…lm‰ÔiùsõMÖ)ÍȆ~¸‡{øÎÇ-enjÒ©"ÏV™Î¦¬Hx‰%!Y*LC*rât*ˆó1ç¦,|ã᠙R½&iA}‹Tlô‡~«Ù7(X9–¥-,Ôã¿Åæ8X˜–,‚[Íó°k~Fše5’Ó`§1=MÇoÈûÑ듦Fïpؑò1ªœ°£;¶‡MìcÓ±OéßaöÝtg¹41FÈE+Ç=Őq¬¶¯aÜÖ$PŽô¾ëVOowÕè“ daíÄûñ#¦«]¿¿¬}´¯2mì:†¯#ãm<=¬/Yjîgdø«³´Ð¹7`q‚½úܕ‹ªã»…ú|ÕAÂãZiöé‚xCéë1ZÂóÑÜ»Âk~C®W™L¸‰ÄrË+˜ã.ëˉðÛZôÈ­>Ø/©†QÏ SôàNâA›Àè?„CR#·+KäښuˆÅö—äª|«}Ñ9xÈ«³à'ROՌv¼÷gxÏùinO[5ýê#7W•Kâˆð⌍”X`ÅI˜°a‰¬Kr"ˆr,‹ÓÖk(nMÇ5oLȸ~)T^å„™•B‰²¢ iœLY>æâ ã'ñ¬3ˆSoÍÆq›«*OB)aÃÙTŽMÙO9V’fœ2M82‘»jŠÓý¥Þ%¾ðœ |m=d@>¬>°‡äãÕß_ =B×ÇS·Mß"Æs||ËèšëX&£;bœkÆÒ~÷˜ÅݞhÚ7Œ‡ôª±2¢øÏ_Oøáîœq‘¥á SO¿…n`!Æd<áa ¢w30šWáša쁪I#˜Þ½[amiÚ¨†«h,x«éOZ]RÜgÓe»[s{oI{äè¨ívÌôhÝÝYè¦ÞâCØö8|”ôe÷­B'q5¼_ûjË´oTφÓJO1Ä;åa‰=õ˟#F%œƒ|ß4F—#‘ '‡© ²¢Báè 1ÏxY”Dž†?:oD6œ<@G'û¡¸Û„t;ºäÛüút‚®ÃíPŒ.!¢ÞÀ"Ï7dûØLTXõ©`CIQ”(4Š&f¡ƒ¼\—»JvP.“ªùÓ°×*A‘V=Ž«E6}iIÞ.< âÏ4­ÃïÉ»é=cÔ×"-ú‘zF>óÁ„òr"GŠØLÝ©OáÒ§”DtSƒßèû×ó^—)ui ÅãF=8tÆ»”VÅ»«#kD‹ÑèåZQ³H3EW«Cc¦Ü¾>•d³ÎhÁ”9S>P&]%“'LÑ}Cƒ¦¤Ý‚^¹]G´‰¼ Óou¼ Y$L)<—r›§E«zA¢”¤fI7Õºm«e°¢ad»MÀ҄ ‰baôý|X¾³„"¢@O„Æˊ±(°D‰&ìŒ$‘¨Ì8yÆoÊwÔßÆM’ Îâ?¨åÉ°–ã-IJøßD)Ùôm9ÿ_ë2 RR”Màßû½}Û{ À_|‚QÕ;õ¼ûÒ¯QúnPoOUï{ Û<{Y§ë¬È³_Šhß /îóçÖ¡ÇZ@G‚þYu\¬nÈ7(ǚm_lt¤šÿ’©ÿPK ³€x\Ùî!å Y customXml/itemProps5.xml±NÃ0†wžÂÊâɵJÚTI*“©+‰Õ8—Ô"¶#Û$Ä»ã¨b ã'}ÿwW?õ„ÞÁyeM…Ó Ì´½2c…ŸŸ:²ÇÈaz1Y6뛲÷‡^áƒup  QĘ8óUra>Pêå´ð;ƒ‰ËÁ:-BŒn¤v”„ÖÊEƒ 4c,§r‰,ý¢§E¶ŠÈS[%_|Çx“uiº»‚ls^¾ç;’Í}ËÚmš²ï¤^}.…0ø¿qå-NýGlòMŒp1ÒÄz#>^osF~sBë’^õÑëÔ?PK ³€x\»„Jâ½ ' customXml/_rels/item5.xml.relsÏ1K1†áÞ_Ò¤r³ '"›½F„ëDV° ÙÙÝ`f&dædïßVXØ~ÅóñNjù‚&™)¸»®w(ñœi î}z¹}tF4ÒwqÇñfxƒ53ɖ«˜I°›j}ò^ҥ㠴cY¸aT鸭¾ÆôWð÷}ÿàÛoÎW¦9ÍÁ¶Ó|°fºTøÍ˒
2025-2026 Bill 1039 Text of Previous Version (Mar.
19, 2026) - South Carolina Legislature Online South Carolina General Assembly126th Session, 2025-2026Bill 1039Indicates Matter StrickenIndicates New Matter(Text matches printed bills.
Document has been reformatted to meet World Wide Web specifications.)                 A bill   TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-190, RELATING TO SCHEDULE I SUBSTANCES, SO AS TO ADD SUBSTITUTED TRYPTAMINES TO THE LIST OF SCHEDULE I SUBSTANCES.
  Be it enacted by the General Assembly of the State of South Carolina:
  SECTION 1.  Section 44-53-190(D) of the S.C.
Code is amended to read:
      (D) Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
       1.
3,4-methylenedioxy amphetamine        2.
5-methoxy-3,4-methylenedioxy amphetamine        3.
3,4-methylenedioxymethamphetamine (MDMA)        4.
3,4,5-trimethoxy amphetamine        5.
Bufotenine        6.
Diethyltryptamine (DET)        7.
Dimethyltryptamine (DMT)        8.5.
4-methyl-2,5-dimethoxyamphetamine (STP)        9.6.
Ibogaine        10.7.
Lysergic acid diethylamide (LSD)        11.8.
Marijuana        12.9.
Mescaline        13.10.
Peyote        14.11.
N-ethyl-3-piperidyl benzilate        15.12.
N-methyl-3-piperidyl benzilate        16.13.
Psilocybin        17.14.
Psilocyn        18.15.
Tetrahydrocannabinol (THC)        19.16.
2,5-dimethoxyamphetamine        20.17.
4-bromo-2,5-dimethoxyamphetamine        21.18.
4-Methoxyamphetamine        22.19.
Thiophene analog of phencyclidine        23.20.
Parahexyl        24.21.
Synthetic cannabinoids.-Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:
           a.
Naphthoylindoles.
Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220.
           b.
Naphthylmethylindoles.
Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
           c.
Show all 100 changed rows (60 more)
Previous
Latest
Naphthoylpyrroles.
Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Including, but not limited to, JWH-307, JWH-370, JWH-176.
           d.
Naphthylmethylindenes.
Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
           e.
Phenylacetylindoles.
Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251.
           f.
Cyclohexylphenols.
Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent.
Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.
           g.
Benzoylindoles.
Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233.
           h.
2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (WIN 55,212-2).
           i.
9-(hydroxymethyl)-6,6-dimethy l-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211).
           j.
Adamantoylindoles.
Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent.
       22.
Substituted Tryptamines.
Any material, compound, mixture, or preparation containing a 2-(1H-indol-3-yl)ethanamine, for example tryptamine, structure with or without mono- or di-substitution of the amine nitrogen with alkyl or alkenyl groups, or by inclusion of the amino nitrogen atom in a cyclic structure, whether or not substituted at the alpha position with an alkyl group, whether or not substituted on the indole ring to any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy groups, including, but not limited to:
           a.
Bufotenine,            b.
DET (Diethyltryptamine),            c.
DMT (Dimethyltryptamine),            d.
Methyltryptamine,            e.
5-MeO-DMT (5-Methoxy-N,N,Dimethyltryptamine),            f.
5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine),            g.
MET (N-Methyl-N-ethyltryptamine),            h.
DALT (N,N-Diallyltryptamine),            i.
EiPT (N-Ethyl-N-isopropyltryptamine),            j.
MiPT (N-Methyl-N-isopropyltryptamine),            k.
5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine),            l.
5-Hydroxy-N-methyltryptamine,            m.
5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine),            n.
5-MeO-AMT (5-Methoxy-alpha-methyltryptamine),            o.
5-Me-DMT (5-Methyl-N,N-dimethyltryptamine),            p.
DiPT (N,N-Diisopropyltryptamine),            q.
DPT (N,N-Dipropyltryptamine),            r.
4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine),            s.
5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine),            t.
4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine),            u.
4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine),            v.
4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine),            x.
4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine),            y.
4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-isopropyltryptamine),            z.
Methyl-alpha-ethyltryptamine,            aa.
Bromo-DALT (Bromo-N,N-diallyltryptamine),            bb.
6-MeO-DMT (6-methoxy-N,N-dimethyltryptamine),            cc.
5-OH-DMT (5-hydroxy-N,N-dimethyltryptamine),            dd.
4-AcO-DET (4-Acetoxy-N,N-diethyltryptamine).
  SECTION 2.  This act takes effect upon approval by the Governor.
----XX---- This web page was last updated on March 19, 2026 at 11:38 AM
⬇ Download PDF
View plain text versions (2)
  • 03/19/2026 View text Current html
  • Introduced Filed vnd.openxmlformats-officedocument.wordprocessingml.document

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill adds substituted tryptamines to the list of Schedule I substances under South Carolina law.

  • Section 44-53-190

    Substituted Tryptamines. Any material, compound, mixture, or preparation containing a 2-(1H-indol-3-yl)ethanamine, for example tryptamine, structure with or without mono- or di-substitution of the amine nitrogen with alkyl or alkenyl groups, or by inclusion of the amino nitrogen atom in a cyclic structure, whether or not substituted at the alpha position with an alkyl group, whether or not substituted on the indole ring to any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy groups, including, but not limited to: a. Bufotenine, b. DET (Diethyltryptamine), c. DMT (Dimethyltryptamine), d. Methyltryptamine, e. 5-MeO-DMT (5-Methoxy-N,N,Dimethyltryptamine), f. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine), g. MET (N-Methyl-N-ethyltryptamine), h. DALT (N,N-Diallyltryptamine), i. EiPT (N-Ethyl-N-isopropyltryptamine), j. MiPT (N-Methyl-N-isopropyltryptamine), k. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine), l. 5-Hydroxy-N-methyltryptamine, m. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine), n. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine), o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine), p. DiPT (N,N-Diisopropyltryptamine), q. DPT (N,N-Dipropyltryptamine), r. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine), s. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine), t. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine), u. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine), v. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine), x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine), y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-isopropyltryptamine), z. Methyl-alpha-ethyltryptamine, aa. Bromo-DALT (Bromo-N,N-diallyltryptamine), bb. 6-MeO-DMT (6-methoxy-N,N-dimethyltryptamine), cc. 5-OH-DMT (5-hydroxy-N,N-dimethyltryptamine), dd. 4-AcO-DET (4-Acetoxy-N,N-diethyltryptamine).

    This change formally classifies substituted tryptamines as Schedule I controlled substances in South Carolina.

Action History

  1. Referred to Committee on Medical Affairs

  2. Introduced and read first time

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 0 co-sponsors · 167 not signed on

Sponsors (3)

Co-sponsors (0)

None.

Not signed on (167)

167 members have not signed on to this bill.

Show all 167 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S 1039 do?
A BILL TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-190, RELATING TO SCHEDULE I SUBSTANCES, SO AS TO ADD SUBSTITUTED TRYPTAMINES TO THE LIST OF SCHEDULE I SUBSTANCES.
Who sponsors S 1039?
S 1039 is sponsored by Senator Everett Stubbs, Senator Stephen L. Goldfinch, and Senator Wes Climer.
What is the current status of S 1039?
This bill is in committee in the Senate. Introduced March 19, 2026. It must pass committee before a floor vote.
Where can I track S 1039?
Track S 1039 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 1039

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 1039

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →